keyword
https://read.qxmd.com/read/38676300/quantitative-brain-stem-assessment-in-discriminating-neurodegenerative-disorders-from-normal-pressure-hydrocephalus
#21
JOURNAL ARTICLE
Charalampos Georgiopoulos, Stergios Papadimitriou, Dag Nyholm, Lena Kilander, Malin Löwenmark, David Fällmar, Johan Virhammar
BACKGROUND AND PURPOSE: Differentiating idiopathic normal pressure hydrocephalus (iNPH) from neurodegenerative disorders such as progressive supranuclear palsy (PSP), Multiple System Atrophy-parkinsonian type (MSA-P), and vascular dementia (VaD) is challenging due to overlapping clinical and neuroimaging findings. This study assesses if quantitative brain stem and cerebellum metrics can aid in this differentiation. METHODS: We retrospectively compared the sagittal midbrain area, midbrain to pons ratio, MR parkinsonism index (MRPI), and cerebellar atrophy in 30 PSP patients, 31 iNPH patients, 27 MSA-P patients, 32 VaD patients, and 25 healthy controls...
April 26, 2024: Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging
https://read.qxmd.com/read/38674252/exploring-the-spectrum-of-visual-illusions-and-other-minor-hallucinations-in-patients-with-parkinson-s-disease-in-lithuania
#22
JOURNAL ARTICLE
Neringa Jucevičiūtė, Renata Balnytė, Ovidijus Laucius
Background and Objectives : Parkinson's disease (PD) is associated with various non-motor symptoms, including minor hallucinations, comprising visual illusions and presence and passage hallucinations. Despite their occurrence, even in newly diagnosed PD patients, data regarding the prevalence and characteristics of minor hallucinations, visual illusions in particular, remain limited. The aim of this study was to address this knowledge gap by assessing the prevalence of minor hallucinations in PD patients, with a focus on visual illusions...
April 6, 2024: Medicina
https://read.qxmd.com/read/38673657/trace-elements-in-alzheimer-s-disease-and-dementia-the-current-state-of-knowledge
#23
REVIEW
Magdalena Tyczyńska, Marta Gędek, Adam Brachet, Wojciech Stręk, Jolanta Flieger, Grzegorz Teresiński, Jacek Baj
Changes in trace element concentrations are being wildly considered when it comes to neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. This study aims to present the role that trace elements play in the central nervous system. Moreover, we reviewed the mechanisms involved in their neurotoxicity. Low zinc concentrations, as well as high levels of copper, manganese, and iron, activate the signalling pathways of the inflammatory, oxidative and nitrosative stress response. Neurodegeneration occurs due to the association between metals and proteins, which is then followed by aggregate formation, mitochondrial disorder, and, ultimately, cell death...
April 19, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38668880/enhanced-spine-stability-and-survival-lead-to-increases-in-dendritic-spine-density-as-an-early-response-to-local-alpha-synuclein-overexpression-in-mouse-prefrontal-cortex
#24
JOURNAL ARTICLE
Peter J Bosch, Gemma Kerr, Rachel Cole, Charles A Warwick, Linder H Wendt, Akash Pradeep, Emma Bagnall, Georgina M Aldridge
Lewy Body Dementias (LBD), including Parkinson's disease dementia and Dementia with Lewy Bodies, are characterized by widespread accumulation of intracellular alpha-Synuclein protein deposits in regions beyond the brainstem, including in the cortex. However, the impact of local pathology in the cortex is unknown. To investigate this, we employed viral overexpression of human alpha-Synuclein protein targeting the mouse prefrontal cortex (PFC). We then used in vivo 2-photon microscopy to image awake head-fixed mice via an implanted chronic cranial window to assess the early consequences of alpha-Synuclein overexpression in the weeks following overexpression...
April 26, 2024: Cellular and Molecular Neurobiology
https://read.qxmd.com/read/38668129/neurocognitive-impairment-and-social-cognition-in-parkinson-s-disease-patients
#25
REVIEW
Triantafyllos Doskas, Konstantinos Vadikolias, Konstantinos Ntoskas, George D Vavougios, Dimitrios Tsiptsios, Polyxeni Stamati, Ioannis Liampas, Vasileios Siokas, Lambros Messinis, Grigorios Nasios, Efthimios Dardiotis
In addition to motor symptoms, neurocognitive impairment (NCI) affects patients with prodromal Parkinson's disease (PD). NCI in PD ranges from subjective cognitive complaints to dementia. The purpose of this review is to present the available evidence of NCI in PD and highlight the heterogeneity of NCI phenotypes as well as the range of factors that contribute to NCI onset and progression. A review of publications related to NCI in PD up to March 2023 was performed using PubMed/Medline. There is an interconnection between the neurocognitive and motor symptoms of the disease, suggesting a common underlying pathophysiology as well as an interconnection between NCI and non-motor symptoms, such as mood disorders, which may contribute to confounding NCI...
April 16, 2024: Neurology International
https://read.qxmd.com/read/38665526/highly-tunable-bimane-based-fluorescent-probes-design-synthesis-and-application-as-a-selective-amyloid-binding-dye
#26
JOURNAL ARTICLE
Yarra Venkatesh, Nicholas P Marotta, Virginia M-Y Lee, E James Petersson
Small molecule fluorescent probes are indispensable tools for a broad range of biological applications. Despite many probes being available, there is still a need for probes where photophysical properties and biological selectivity can be tuned as desired. Here, we report the rational design and synthesis of a palette of fluorescent probes based on the underexplored bimane scaffold. The newly developed probes with varied electronic properties show tunable absorption and emission in the visible region with large Stokes shifts...
April 24, 2024: Chemical Science
https://read.qxmd.com/read/38663633/rna-sequencing-of-olfactory-bulb-in-parkinson-s-disease-reveals-gene-alterations-associated-with-olfactory-dysfunction
#27
JOURNAL ARTICLE
Cécilia Tremblay, Sidra Aslam, Jessica E Walker, Ileana Lorenzini, Anthony J Intorcia, Richard A Arce, Parichita Choudhury, Charles H Adler, Holly A Shill, Erika Driver-Dunckley, Shyamal Mehta, Ignazio S Piras, Christine M Belden, Alireza Atri, Thomas G Beach, Geidy E Serrano
The olfactory bulb is involved early in the pathophysiology of Parkinson's disease (PD), which is consistent with the early onset of olfactory dysfunction. Identifying the molecular mechanisms through which PD affects the olfactory bulb could lead to a better understanding of the pathophysiology and etiology of olfactory dysfunction in PD. We specifically aimed to assess gene expression changes, affected pathways and co-expression network by whole transcriptomic profiling of the olfactory bulb in subjects with clinicopathologically defined PD...
April 23, 2024: Neurobiology of Disease
https://read.qxmd.com/read/38663126/lithium-versus-anticonvulsants-and-the-risk-of-physical-disorders-results-from-a-comprehensive-long-term-nation-wide-population-based-study-emulating-a-target-trial
#28
JOURNAL ARTICLE
Lars Vedel Kessing, Mark Bech Knudsen, Helene Charlotte Wiese Rytgaard, Christian Torp-Pedersen, Michael Berk
Bipolar disorder is associated with increased rates of many physical disorders, but the effects of medication are unclear. We systematically investigated the associations between sustained use of first line maintenance agents, lithium versus lamotrigine and valproate, and the risk of physical disorders using a nation-wide population-based target trial emulation covering the entire 5.9 million inhabitants in Denmark. We identified two cohorts. Cohort 1: patients with a diagnosis of bipolar disorder prior to first purchase (N = 12...
April 24, 2024: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://read.qxmd.com/read/38662269/hypotensive-episodes-at-24-h-ambulatory-blood-pressure-monitoring-predict-adverse-outcomes-in-parkinson-s-disease
#29
JOURNAL ARTICLE
Fabrizio Vallelonga, Matteo Valente, Marta Maria Tangari, Anna Covolo, Valeria Milazzo, Cristina Di Stefano, Gabriele Sobrero, Marta Giudici, Alberto Milan, Franco Veglio, Leonardo Lopiano, Simona Maule, Alberto Romagnolo
PURPOSE: Neurogenic orthostatic hypotension (nOH) is a frequent nonmotor feature of Parkinson's disease (PD), associated with adverse outcomes. Recently, 24-h ambulatory blood pressure monitoring (ABPM) showed good accuracy in diagnosing nOH. This study aims at evaluating the prognostic role of ABPM-hypotensive episodes in predicting PD disability milestones and mortality and comparing it to the well-defined prognostic role of bedside nOH. METHODS: Patients with PD who underwent ABPM from January 2012 to December 2014 were retrospectively enrolled and assessed for the development of falls, fractures, dementia, bed/wheelchair confinement, hospitalization, and mortality, during an up-to-10-year follow-up...
April 25, 2024: Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society
https://read.qxmd.com/read/38659706/branched-chain-amino-acids-and-the-risks-of-dementia-alzheimer-s-disease-and-parkinson-s-disease
#30
JOURNAL ARTICLE
Yidong Fu, Yue Wang, Huiming Ren, Xu Guo, Liyuan Han
BACKGROUND: We aimed to examine the association between blood levels of Branched-chain amino acids (BCAAs) - specifically isoleucine, leucine, and valine - and the susceptibility to three neurodegenerative disorders: dementia, Alzheimer's disease (AD), and Parkinson's disease (PD). METHODS: Based on data from the UK Biobank, a Cox proportional hazard regression model and a dose-response relationship were used to analyze the association between BCAAs and the risks of dementia, AD, and PD...
2024: Frontiers in Aging Neuroscience
https://read.qxmd.com/read/38654628/prevalence-of-and-annual-conversion-rates-to-mild-cognitive-impairment-and-dementia-prospective-longitudinal-study-of-an-essential-tremor-cohort
#31
JOURNAL ARTICLE
Ali Ghanem, Diane S Berry, Allison Burkes, Natalie Grill, Talía M Hall, Kira A Hart, Nora C Hernandez, Silvia Chapman, Vibhash D Sharma, Edward D Huey, Stephanie A Cosentino, Elan D Louis
OBJECTIVE: Despite recent attention to cognitive impairment in essential tremor, few studies examine rates of conversion to diagnoses of mild cognitive impairment and dementia. Development of dementia in essential tremor is associated with loss of functional ability and a doubling of mortality rate. This prospective, longitudinal study comprehensively reports the prevalence and incidence of, and the annual rates of conversion to, mild cognitive impairment and dementia in an essential tremor cohort...
April 24, 2024: Annals of Neurology
https://read.qxmd.com/read/38654300/alteration-of-medial-temporal-lobe-metabolism-related-to-alzheimer-s-disease-and-dementia-with-lewy-bodies
#32
JOURNAL ARTICLE
Sungwoo Kang, Seun Jeon, Young-Gun Lee, Byoung Seok Ye
BACKGROUND: Association of medial temporal lobe (MTL) metabolism with Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) has not been evaluated considering their mixed disease (MD). METHODS: 131 patients with AD, 133 with DLB, 122 with MD, and 28 normal controls (NCs) underwent neuropsychological tests, assessments for parkinsonism, cognitive fluctuation (CF), and visual hallucinations (VH), and 18 F-fluorodeoxyglucose PET to quantify MTL metabolism in the amygdala, hippocampus, and entorhinal cortex...
April 23, 2024: Alzheimer's Research & Therapy
https://read.qxmd.com/read/38652714/neuronal-cell-cycle-reentry-events-in-the-aging-brain-are-more-prevalent-in-neurodegeneration-and-lead-to-cellular-senescence
#33
JOURNAL ARTICLE
Deng Wu, Jacquelyne Ka-Li Sun, Kim Hei-Man Chow
Increasing evidence indicates that terminally differentiated neurons in the brain may recommit to a cell cycle-like process during neuronal aging and under disease conditions. Because of the rare existence and random localization of these cells in the brain, their molecular profiles and disease-specific heterogeneities remain unclear. Through a bioinformatics approach that allows integrated analyses of multiple single-nucleus transcriptome datasets from human brain samples, these rare cell populations were identified and selected for further characterization...
April 2024: PLoS Biology
https://read.qxmd.com/read/38651546/risk-factors-for-inadequate-bowel-preparation-before-colonoscopy-a-meta-analysis
#34
REVIEW
Lina Feng, Jialun Guan, Ruonan Dong, Kai Zhao, Mingyu Zhang, Suhong Xia, Yu Zhang, Liping Chen, Fang Xiao, Jiazhi Liao
OBJECTIVE: This meta-analysis aimed to comprehensively explore the risk factors for inadequate bowel preparation (IBP). METHODS: We searched the Embase, PubMed, Web of Science, and The Cochrane Library databases up to August 24, 2023, to identify observational studies and randomized controlled trials (RCTs) that examined risk factors for IBP. A random effects model was used to pool the adjusted odds ratios and 95% confidence intervals. RESULTS: A total of 125 studies (91 observational studies, 34 RCTs) were included...
April 23, 2024: Journal of Evidence-based Medicine
https://read.qxmd.com/read/38645146/synaptic-gene-expression-changes-in-frontotemporal-dementia-due-to-the-mapt-10-16-mutation
#35
Owen Dando, Robert McGeachan, Jamie McQueen, Paul Baxter, Nathan Rockley, Hannah McAlister, Adharsh Prasad, Xin He, Declan King, Jamie Rose, Phillip B Jones, Jane Tulloch, Siddharthan Chandran, Colin Smith, Giles Hardingham, Tara L Spires-Jones
Mutations in the MAPT gene encoding tau protein can cause autosomal dominant neurodegenerative tauopathies including frontotemporal dementia (often with Parkinsonism). In Alzheimer's disease, the most common tauopathy, synapse loss is the strongest pathological correlate of cognitive decline. Recently, PET imaging with synaptic tracers revealed clinically relevant loss of synapses in primary tauopathies; however, the molecular mechanisms leading to synapse degeneration in primary tauopathies remain largely unknown...
April 12, 2024: medRxiv
https://read.qxmd.com/read/38644417/a-dynamic-computational-model-of-the-parallel-circuit-on-the-basal-ganglia-cortex-associated-with-parkinson-s-disease-dementia
#36
JOURNAL ARTICLE
Hao Yang, XiaoLi Yang, SiLu Yan
The cognitive impairment will gradually appear over time in Parkinson's patients, which is closely related to the basal ganglia-cortex network. This network contains two parallel circuits mediated by putamen and caudate nucleus, respectively. Based on the biophysical mean-field model, we construct a dynamic computational model of the parallel circuit in the basal ganglia-cortex network associated with Parkinson's disease dementia. The simulated results show that the decrease of power ratio in the prefrontal cortex is mainly caused by dopamine depletion in the caudate nucleus and is less related to that in the putamen, which indicates Parkinson's disease dementia may be caused by a lesion of the caudate nucleus rather than putamen...
April 21, 2024: Biological Cybernetics
https://read.qxmd.com/read/38642587/associations-between-recreational-screen-time-and-brain-health-in-middle-aged-and-older-adults-a-large-prospective-cohort-study
#37
JOURNAL ARTICLE
Chenjie Xu, Zhi Cao, Zuolin Lu, Yabing Hou, Yaogang Wang, Xinyu Zhang
OBJECTIVES: To investigate the associations of recreational screen time with risks of brain-related disorders (dementia, stroke, or Parkinson's disease) and neuroimaging features. DESIGN: Prospective cohort study. SETTING AND PARTICIPANTS: A total of 407,792 participants from the UK Biobank who were free of dementia, stroke, or Parkinson's disease at enrollment (2006-2010). METHODS: TV viewing and time spent using the computer were self-reported at baseline...
April 17, 2024: Journal of the American Medical Directors Association
https://read.qxmd.com/read/38641563/increased-frequency-and-mortality-in-persons-with-neurological-disorders-during-covid-19
#38
JOURNAL ARTICLE
Candace M Marsters, Jeffrey A Bakal, Grace Y Lam, Finlay A McAlister, Christopher Power
Determining the frequency and outcomes of neurological disorders associated with COVID-19 is imperative for understanding risks as well as recognition of emerging neurological disorders. We investigated the susceptibility and impact of SARS-CoV-2 infection among persons with premorbid neurological disorder rs, as well as the post-infection incidence of neurological sequelae in a case-control population-based cohort. Using health service data collected from March 1, 2020, to June 30, 2021, we constructed a cohort of SARS-CoV-2 RNA-positive (n=177,892) and -negative (n=177,800) adults who were age-, sex-, and comorbidity-matched and underwent RT- PCR testing at similar times...
April 20, 2024: Brain
https://read.qxmd.com/read/38640601/dna-repair-deficiencies-and-neurodegeneration
#39
JOURNAL ARTICLE
Baptiste Ropert, Christian Gallrein, Björn Schumacher
Neurodegenerative diseases are the second most prevalent cause of death in industrialized countries. Alzheimer's Disease is the most widespread and also most acknowledged form of dementia today. Together with Parkinson's Disease they account for over 90 % cases of neurodegenerative disorders caused by proteopathies. Far less known are the neurodegenerative pathologies in DNA repair deficiency syndromes. Such diseases like Cockayne - or Werner Syndrome are described as progeroid syndromes - diseases that cause the premature ageing of the affected persons, and there are clear implications of such diseases in neurologic dysfunction and degeneration...
April 16, 2024: DNA Repair
https://read.qxmd.com/read/38640172/parkinson-s-disease-and-dementia-with%C3%A2-lewy-bodies-one-and-the-same
#40
REVIEW
Per Borghammer, Niels Okkels, Daniel Weintraub
The question whether Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB) are expressions of the same underlying disease has been vigorously debated for decades. The recently proposed biological definitions of Lewy body disease, which do not assign any particular importance to the dopamine system over other degenerating neurotransmitter systems, has once more brought the discussion about different types of Lewy body disease to the forefront. Here, we briefly compare PDD and DLB in terms of their symptoms, imaging findings, and neuropathology, ultimately finding them to be indistinguishable...
April 12, 2024: Journal of Parkinson's Disease
keyword
keyword
113542
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.